Eton Pharmaceuticals Inc

NASDAQ:ETON   3:59:53 PM EDT
2.39
-0.04 (-1.65%)
Debt Financing / Related

Eton Announces Sale Of Hospital Products

Published: 06/24/2022 12:37 GMT
Eton Pharmaceuticals Inc (ETON) - Eton Pharmaceuticals Announces Sale of Hospital Products.
Eton Pharmaceuticals Inc - Sold Its Rights in Biorphen®, Rezipres®, and Cysteine Hydrochloride Products for Total Payments of Up to $50 Million.
Eton Pharmaceuticals Inc - Going Forward, Eton's Commercial Portfolio Will Exclusively Focus on Products That Treat Rare Diseases.
Eton Pharma- Co's Royalty Portfolio is Eligible to Get Up to $70 Million in Future Milestone Payments From 6 Products, Royalties on Sales From 4 Products.